Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Melanoma

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 12 articles: HTML format

Single Articles

September 2025
1. MILLER S, Cano M, Kawalerski R, Shi MD, et al
   Elevated Lactic Acid Levels in the Aqueous Humor May Be an Indicator of Uveal Melanoma.
   Am J Ophthalmol. 2025 Sep 11:S0002-9394(25)00485.
   PubMed     Abstract available
   
   
   July 2025
2. KADAKIA AB, Ali AM, Chuang AZ, Schefler AC, et al
   Comparison of Patients with Observed High-Risk Choroidal Nevi That Evolved into Melanomas vs. Patients with Immediately Treated Uveal Melanomas.
   Am J Ophthalmol. 2025 Jul 2:S0002-9394(25)00347.
   PubMed     Abstract available
   
   
   May 2025
3. CHOU HD, Heimann H, Damato BE, Hussain RN, et al
   Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery.
   Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278.
   PubMed     Abstract available
   
   
   March 2025
4. MUKIT FA, Terfloth N, Kim IK, Wu F, et al
   Malignant transformation of ocular melanocytoma to uveal melanoma: a clinicopathologic review of three novel unsuspected cases of a likely under-recognized phenomenon, with review of the literature and molecular genetic data.
   Am J Ophthalmol. 2025 Mar 31:S0002-9394(25)00164.
   PubMed     Abstract available
   
   
   
5. WANG C, Gu J
   Giant Conjunctival Melanoma.
   Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00156.
   PubMed    
   
   
   
6. NISSEN K, Kiilgaard JF, Fili M, Seregard S, et al
   Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study.
   Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00115.
   PubMed     Abstract available
   
   
   December 2024
7. CAPPELLI L, Khan MM, Shields CL, Lally SE, et al
   Favorable outcomes of patients with high-risk uveal melanoma treated with a novel LINAC-based frameless fractionated stereotactic radiosurgery.
   Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00564.
   PubMed     Abstract available
   
   
   October 2024
8. TIAN H, Shi H, Chen J, Zhu T, et al
   Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value.
   Am J Ophthalmol. 2024 Oct 16:S0002-9394(24)00479.
   PubMed     Abstract available
   
   
   July 2024
9. JUNG H, Kim S, Lee CS, Byeon SH, et al
   Real-world incidence of incident noninfectious uveitis in patients treated with BRAF inhibitors: a nationwide clinical cohort study.
   Am J Ophthalmol. 2024 Jul 6:S0002-9394(24)00300.
   PubMed     Abstract available
   
   
   January 2024
10. HUANG JJ, Saleem A, Liao EX, Larocque M, et al
    Incidence of Strabismus Post Plaque Brachytherapy in Patients with Uveal Melanoma.
    Am J Ophthalmol. 2024 Jan 31:S0002-9394(24)00035.
    PubMed     Abstract available
    
    
    December 2023
11. HASEGAWA N, Teh BS, Tran K, Ivey F, et al
    Retrospective Analysis of Radiation-induced Complications of Uveal Melanoma Patients Treated with Brachytherapy in the Era of Anti-VEGF.
    Am J Ophthalmol. 2023 Dec 9:S0002-9394(23)00511.
    PubMed     Abstract available
    
    
    November 2023
12. CHOUDHRY HS, Patel AM, Nguyen HN, Kaleem MA, et al
    Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
    Am J Ophthalmol. 2023 Nov 11:S0002-9394(23)00455.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.